Table 1

 Sample characteristics at baseline. Data are no (%) unless stated otherwise

WSD telehealth trial (parent trial)WSD telehealth questionnaire study (nested study)
Baseline cohortAvailable case cohortComplete case cohort
TH (n=1605; 49.7%)UC (n=1625; 50.3%)Total (n=3230)TH (n=845; 53.7%)UC (n=728; 46.3%)Total (n=1573)TH (n=670; 55.8%)UC (n=531; 44.2%)Total (n=1201)TH (n=431; 56.8%)UC (n=328; 43.2%)Total (n=759)
WSD site
Cornwall566 (35.3)625 (38.5)1191 (36.9)256 (30.3)234 (32.1)490 (31.2)221 (33.0)168 (31.6)389 (32.4)149 (34.6)107 (32.6)256 (33.7)
Kent583 (36.3)595 (36.6)1178 (36.5)343 (40.6)283 (38.9)626 (39.8)285 (42.5)216 (40.7)501 (41.7)202 (46.9)153 (46.6)355 (46.8)
Newham456 (28.4)405 (24.9)861 (26.7)246 (29.1)211 (29.0)457 (29.1)164 (24.5)147 (27.7)311 (25.9)80 (18.6)68 (20.7)148 (19.5)
Sex
Female664 (41.4)658 (40.5)1322 (40.9)350 (41.4)290 (39.8)640 (40.7)271 (40.4)207 (39.0)478 (39.8)171 (39.7)124 (37.8)295 (38.9)
Male941 (58.6)967 (59.5)1908 (59.1)495 (58.6)438 (60.2)933 (59.3)399 (59.6)324 (61.0)723 (60.2)260 (60.3)204 (62.2)464 (61.1)
Ethnicity*
Non-white187 (11.7)†180 (11.1)†367 (11.4)†111.5 (13.2)*99.9 (13.7)*211.4 (13.4)*75 (11.2)68 (12.8)143 (11.9)30 (7.0)23 (7.0)53 (7.0)
White1251 (77.9)†1264 (77.8)†2515 (77.9)†733.5 (86.8)*628.1 (86.3)*1361.6 (86.6)*595 (88.8)463 (87.2)1058 (88.1)401 (93.0)305 (93.0)706 (93.0)
Data missing167 (10.4)†181 (11.1)†348 (10.8)†
Long term condition diagnoses‡
COPD902 (56.2)962 (59.2)1864 (57.7)416 (49.2)327 (44.9)743 (47.2)339 (50.6)237 (44.6)576 (48.0)238 (55.2)158 (48.2)396 (52.2)
Diabetes570 (35.5)485 (29.8)1055 (32.7)339 (40.1)283 (38.9)622 (39.5)243 (36.3)205 (38.6)448 (37.3)128 (29.7)108 (32.9)236 (31.1)
Heart failure566 (35.3)581 (35.8)1147 (35.5)336 (39.8)327 (44.9)663 (42.1)284 (42.4)248 (46.7)532 (44.3)178 (41.3)162 (49.4)340 (44.8)
Other (mean (SD))
Age (years)69.68 (11.55)70.80 (11.64)70.24 (11.61)70.11 (11.81)70.61 (11.78)70.34 (11.79)70.14 (10.98)70.46 (11.61)70.28 (11.26)70.61 (9.72)71.21 (11.00)70.87 (10.29)
Deprivation (IMD)*28.34 (14.82)†27.93 (13.53)†28.13 (14.18)†27.71 (15.01)*28.55 (13.79)*28.10 (14.46)*26.15 (14.24)*28.10 (13.77)*27.01 (14.07)*24.44 (13.62)*25.76 (12.96)*25.01 (13.35)*
No of comorbidities1.75 (1.79)1.80 (1.82)1.77 (1.81)1.84 (1.80)2.02 (1.86)1.92 (1.83)1.85 (1.78)2.00 (1.88)1.92 (1.83)1.72 (1.76)1.93 (1.84)1.81 (1.80)
No of TH devices2.68 (0.70)0.04 (0.36)1.35 (1.43)2.77 (0.68)0.07 (0.49)1.52 (1.47)2.74 (0.69)0.07 (0.47)1.56 (1.46)2.69 (0.65)0.04 (0.32)1.54 (1.42)

TH=telehealth; UC=usual care; COPD=chronic obstructive pulmonary disease; IMD=index of multiple deprivation score; available case cohort=includes baseline assessments and short term or long term assessment; complete case cohort=includes assessments at all three time points (baseline, four months (short term), 12 months (long term)).

*Participants (≤12) had missing data for ethnicity or deprivation in some cohorts of the questionnaire study. Missing values were multiply imputed (m=10), and the values reported are imputed averages.

†The parent trial cohort had more participants than the questionnaire study cohort with missing data for ethnicity (n=348) and deprivation (n=12). These missing values were not imputed; instead, missing values are reported explicitly for ethnicity, while for deprivation we reported the means (and standard deviations) based on 3218 (99.6%) participants with data available. All other values are based on complete (non-imputed) data.

‡Participants could have had more than one diagnosis; therefore, the percentages do not add up to 100%.